Sadanyl
Category
Sadanyl Brand names, Sadanyl Analogs
Sadanyl Brand Names Mixture
Sadanyl Chemical_Formula
C20H23NS
Sadanyl RX_link
No information avaliable
Sadanyl fda sheet
Sadanyl msds (material safety sheet)
Sadanyl Synthesis Reference
No information avaliable
Sadanyl Molecular Weight
309.469 g/mol
Sadanyl Melting Point
< 25 oC
Sadanyl H2O Solubility
Soluble as HCl salt
Sadanyl State
Liquid
Sadanyl LogP
5.7
Sadanyl Dosage Forms
Tablets (oral, 1 mg)
Sadanyl Indication
Used for the symptomatic treatment of parkinsonism.
Sadanyl Pharmacology
Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.
Sadanyl Absorption
Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.
Sadanyl side effects and Toxicity
Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.
Sadanyl Patient Information
Sadanyl Organisms Affected
Humans and other mammals
